Kevin Holcomb
Overview
Explore the profile of Kevin Holcomb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Assaad M, Hadi K, Tu J, Levine M, Patel M, Deshpande A, et al.
Pathol Res Pract
. 2024 Dec;
266:155773.
PMID: 39673888
Background: Advanced-stage tube-ovarian cancers (TOC) and uterine cancers (UC) significantly contribute to cancer mortality. While surgery achieves clinical remission in most cases, recurrence often necessitates systemic therapy. Recent molecular phenotype...
2.
Hwang S, Awasthi D, Jeong J, Sandoval T, Chae C, Ramos Y, et al.
Nature
. 2024 Oct;
635(8040):1010-1018.
PMID: 39443795
Mounting effective immunity against pathogens and tumours relies on the successful metabolic programming of T cells by extracellular fatty acids. Fatty-acid-binding protein 5 (FABP5) has a key role in this...
3.
Sandoval T, Salvagno C, Chae C, Awasthi D, Giovanelli P, Marin Falco M, et al.
Cancer Discov
. 2024 Jul;
14(10):1901-1921.
PMID: 39073085
Iron accumulation in tumors contributes to disease progression and chemoresistance. Although targeting this process can influence various hallmarks of cancer, the immunomodulatory effects of iron chelation in the tumor microenvironment...
4.
Ahsan M, Webster E, Wolfe I, McGonigle R, Brewer J, Chandler I, et al.
Gynecol Oncol
. 2024 Mar;
183:47-52.
PMID: 38503141
Introduction: Gynecologic and breast cancers share several risk factors. Breast cancer risk assessment tools can identify those at elevated risk and allow for enhanced breast surveillance and chemoprevention, however such...
5.
Hwang S, Awasthi D, Jeong J, Sandoval T, Chae C, Ramos Y, et al.
Res Sq
. 2024 Jan;
PMID: 38168227
Mounting effective immunity against pathogens and tumors relies on the successful metabolic programming of T cells by extracellular fatty acids. During this process, fatty-acid-binding protein 5 (FABP5) imports lipids that...
6.
Webster E, Ahsan M, Kulkarni A, Penate E, Beaumont S, Ma X, et al.
Gynecol Oncol
. 2023 Dec;
181:102-109.
PMID: 38150834
Objectives: HPV vaccination rates remain suboptimal despite proven efficacy. Data suggest misconceptions or lack of knowledge are leading barriers. Our study aimed to develop and pilot a novel interactive education...
7.
Webster E, Ahsan M, Perez L, Levi S, Thomas C, Christos P, et al.
JCO Clin Cancer Inform
. 2023 Nov;
7:e2300123.
PMID: 37934933
Purpose: Most individuals with a hereditary cancer syndrome are unaware of their genetic status to underutilization of hereditary cancer risk assessment. Chatbots, or programs that use artificial intelligence to simulate...
8.
Kulkarni A, Monu N, Ahsan M, Orakuwue C, Ma X, McDougale A, et al.
J Telemed Telecare
. 2023 Oct;
:1357633X231197965.
PMID: 37788366
Objective: To evaluate patient and provider experiences using telemedicine for gynecologic visits among a diverse, low-income population. Methods: Patients attending telemedicine visits at a resident-run gynecology clinic completed a modified...
9.
Narayan P, Ahsan M, Webster E, Perez L, Levi S, Harvey B, et al.
Gynecol Oncol
. 2023 Aug;
177:72-85.
PMID: 37651980
Objective: Approximately 20% of ovarian cancers are due to an underlying germline pathogenic variant. While pathogenic variants in several genes have been well-established in the development of hereditary ovarian cancer...
10.
Miller E, Beaumont S, Ni Zhou Z, Brewer J, Thomas C, Chapman-Davis E, et al.
Gynecol Oncol Rep
. 2023 Jul;
48:101232.
PMID: 37415958
Objectives: To measure prevalence of complementary and alternative medicine (CAM) use in a diverse gynecologic oncology patient population and evaluate how attitudes and beliefs regarding CAM relate to demographic factors....